Partners & Customers
10About Getinge
Getinge is a medical technology company. The company provides equipment, systems, operating rooms, and intensive-care units to the healthcare and the life science industries. The company also operates through the following businesses: Acute Care Therapies, Patient & Post-Acute Care, and Surgical Workflows.
Want to inform investors similar to Getinge about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Getinge News
Sep 19, 2023
Getinge Tue, Sep 19, 2023 14:00 CET Getinge announces that Jeanette Hedén Carlsson has decided to resign after 6 years as Executive Vice President, Brand & Communication, and member of the Executive Team. The process to recruit a successor will start immediately. ”Jeanette has successfully built and developed effective communication and investor engagement, which are important parts of our growth strategy”, says Mattias Perjos, President & CEO at Getinge. “Under her leadership Getinge’s brand recognition has increased on our key markets. I have appreciated her as a colleague and wish her all the best in her next career step”. Jeanette Hedén Carlsson will continue in her current role until December 31, 2023. Media contact:
Getinge Acquisitions
11 Acquisitions
Getinge acquired 11 companies. Their latest acquisition was High Purity New England on May 31, 2023.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
5/31/2023 | Acquired | 5 | ||||
3/14/2023 | Acquired | 4 | ||||
4/28/2022 | Series A | $3.61M | Acquired | 1 | ||
12/23/2021 | ||||||
11/12/2021 | Debt |
Date | 5/31/2023 | 3/14/2023 | 4/28/2022 | 12/23/2021 | 11/12/2021 |
|---|---|---|---|---|---|
Investment Stage | Series A | Debt | |||
Companies | |||||
Valuation | |||||
Total Funding | $3.61M | ||||
Note | Acquired | Acquired | Acquired | ||
Sources | 5 | 4 | 1 |
Getinge Partners & Customers
10 Partners and customers
Getinge has 10 strategic partners and customers. Getinge recently partnered with Anaqua on June 6, 2023.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
6/6/2023 | Vendor | United States | Getinge Selects Anaqua to Provide Single, Centralized IP Management Platform BOSTON , June 06 , 2023 -- Anaqua , Inc. , the leading innovation and intellectual property management technology provider , today announced that global medical technology company Getinge has selected Anaqua , Inc. 's AQX in order to consolidate the management of all its IP assets onto a single , centralized platform . | 3 | |
9/20/2022 | Client | United States | Getinge announces a supply partnership with Medtronic , which recently received CE mark for the Radiant ™ covered stent , the first covered stent indicated for chimney endovascular aneurysm repair . | 4 | |
6/12/2022 | Partner | France | Getinge launches financing program with BNP Paribas Leasing Solutions Getinge announces new partnership with BNP Paribas Leasing Solutions for innovative payment solutions for its European customers . | 2 | |
4/7/2022 | Partner | ||||
3/8/2022 | Client |
Date | 6/6/2023 | 9/20/2022 | 6/12/2022 | 4/7/2022 | 3/8/2022 |
|---|---|---|---|---|---|
Type | Vendor | Client | Partner | Partner | Client |
Business Partner | |||||
Country | United States | United States | France | ||
News Snippet | Getinge Selects Anaqua to Provide Single, Centralized IP Management Platform BOSTON , June 06 , 2023 -- Anaqua , Inc. , the leading innovation and intellectual property management technology provider , today announced that global medical technology company Getinge has selected Anaqua , Inc. 's AQX in order to consolidate the management of all its IP assets onto a single , centralized platform . | Getinge announces a supply partnership with Medtronic , which recently received CE mark for the Radiant ™ covered stent , the first covered stent indicated for chimney endovascular aneurysm repair . | Getinge launches financing program with BNP Paribas Leasing Solutions Getinge announces new partnership with BNP Paribas Leasing Solutions for innovative payment solutions for its European customers . | ||
Sources | 3 | 4 | 2 |
Getinge Team
18 Team Members
Getinge has 18 team members, including current Managing Director, Chris Devlin.
Name | Work History | Title | Status |
|---|---|---|---|
Chris Devlin | Covaris, T2 Biosystems, Microline Surgical, Arrow International, and U.S. Navy | Managing Director | Current |
Name | Chris Devlin | ||||
|---|---|---|---|---|---|
Work History | Covaris, T2 Biosystems, Microline Surgical, Arrow International, and U.S. Navy | ||||
Title | Managing Director | ||||
Status | Current |
Compare Getinge to Competitors
Jarvik Heart is a private company that develops miniaturized heart assist devices for the treatment of severe heart failure.
Teleflex (NYSE: TFX) manufactures and markets surgical instruments and devices in the United States and internationally. It offers surgical instruments, appliances, cardiac devices, and other products. Teleflex was formerly known as Hudson Respiratory Care. The company was founded in 1943 and is based in Wayne, Pennsylvania.
ReliantHeart is a provider in mechanical circulatory support therapies for advanced stage heart failure. The company manufactures the HeartAssist5, a next generation ventricular assist device (VAD) which has CE Mark approval for commercial sale in Europe. The HeartAssist5 is an implantable, electric pump designed for use in patients requiring ventricular support due to end stage heart failure and is the world's only remotely monitored VAD.
BiVACOR develops an artificial heart-pumping device designed to take over the complete function of a patient's failing heart. The compact device comprises a magnetically levitated rotor located between opposing pump casings and leverages rotary blood pump technology to provide the required cardiac output. The company was founded in 2008 and is based in Houston, Texas.
Stryker (NYSE: SYK) develops, manufactures, and markets specialty surgical and medical products worldwide. It offers orthopedic implants, trauma systems, powered surgical instruments, endoscopic systems, and, patient care and handling equipment. It was founded in 1941 and is based in Kalamazoo, Michigan.
ImaCor designs, manufactures, and distributes hTEE technology, the first and only critical care solution enabling clinicians to optimize cardiac performance with continuously-available, direct cardiac visualization over time, collectively serving patients, clinicians, and hospital administrators with the best possible clinical outcomes and cost-effective resource utilization. hTEE technology is enabled through the ZuraTM ultrasound systems and the miniaturized, disposable ClariTEE probe, uniquely designed to remain indwelling for up to 72 hours for episodic assessment of cardiac filling and function. Direct visualization with hTEE enables clinicians to optimize cardiac performance throughout a patient's course of treatment, allowing them to guide and assess the effectiveness of therapies, as well as make critical changes in management at the right time.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
